Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
Rishi Singh,1 Louis Alpern,2 Glenn J Jaffe,3 Robert P Lehmann,4 John Lim,5 Harvey J Reiser,6 Kenneth Sall,7 Thomas Walters,8 Dana Sager91Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, 2The Cataract, Glaucoma, and Refractive Surgery Center, El Paso, TX, 3Duke Eye Center, Duke Reading...
Guardado en:
Autores principales: | Singh R, Alpern L, Jaffe GJ, Lehmann RP, Lim J, Reiser HJ, Sall K, Walters T, Sager D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/68e55cef097947b2af6c0e2cb449dc7a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
por: Yüksel B, et al.
Publicado: (2017) -
Topical nepafenac in the treatment of diabetic macular edema
por: David Callanan, et al.
Publicado: (2008) -
Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
por: Singh RP, et al.
Publicado: (2017) -
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
por: Seenu M Hariprasad, et al.
Publicado: (2009) -
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
por: Giarmoukakis AK, et al.
Publicado: (2020)